Scienza e Tecnologia
ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™
The new funding will drive production and manufacturing scale-up as well as help accelerate global commercial expansion. With this stable footing, ThinkCyte is poised to broaden the impact of its technologies, driving advancements in the life sciences and maintaining its leadership in innovative single-cell analysis and sorting solutions.
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company's flagship product, VisionSort, is the world's first AI-based, dual-mode fluorescence and morphometric cell sorting platform and it partners with major global biopharmaceutical companies and leading academic research institutes to further drive groundbreaking research. For more information, please visit www.thinkcyte.com .
To learn more about research partnerships or other partnering opportunities with ThinkCyte, email contact@thinkcyte.com .
View original content: https://www.prnewswire.co.uk/news-releases/thinkcyte-secures-32-million-in-series-c-funding-to-drive-global-expansion-of-visionsort-302235164.html